Sousa ha dado un puñetazo en la mesa y ha acusado directamente al prestamo de acciones del hundimiento de Zeltia en particular y en general podriamos decir que el tema afecta a muchas empresas .....
No se puede tolerar que 4 Sisinayas se puedan permitir hundir a las empresas ...y a sus accionistas ..... nuestra empresa tiene que Investigar y trabajar muy duro para obtener resultados en los tratamientos contra el Cancer ....enfermedad que aun podemos decir que no existe cura y que practicamente el 50 % lo padeceremos .... a parte nuestra empresa tambien esta en la obligacion de crear valor a sus accionistas ....y lo vivido desde la aprobacion del Yondelis es de Juzgado de Guardia .....
¡¡¡¡ Una Verguenza que pueda ser legal el hundir a posta una empresa !!!! .... muchos son hoy los que estan enviando correos a la CNMV para protestar sobre este tema .....yo aprovecho esta ventana publica para expresar mi repulsa y para que la CNMV realice de una vez por todas su principal funcion .....que es ni mas ni menos que la defensa del Inversor .
17 enero 2008
Pharma Mar Nueva Patente , Nueva Actividad .
ANTITUMOUR COMPOUNDS .
Publication number: WO2008003809
Publication date: 2008-01-10
Inventor: LOPEZ ORTIZ FERNANDO (ES); FERNANDEZ DE LAS NIEVES IGNACI (ES); RUIZ GOMEZ GLORIA (ES); YANEZ RODRIGUEZ VICTOR (ES)
Applicant: PHARMA MAR SA (ES); LOPEZ ORTIZ FERNANDO (ES); FERNANDEZ DE LAS NIEVES IGNACI (ES); RUIZ GOMEZ GLORIA (ES); YANEZ RODRIGUEZ VICTOR (ES)
Classification:
- international: C07F9/36; A61K31/664; A61K31/675; A61P35/00; C07F9/6584; C07F9/00; A61K31/664; A61K31/675; A61P35/00;
- European:
Application number: WO2007ES00398 20070703
Priority number(s): ES20060001793 20060703
Abstract of WO2008003809
The invention relates to compounds having general formula (I) and to the corresponding pharmaceutically-acceptable salts, derivatives, pro-drugs and stereoisomers thereof, (I), which are used for the cytotoxic activity thereof and for use as antitumour agents.
Publication number: WO2008003809
Publication date: 2008-01-10
Inventor: LOPEZ ORTIZ FERNANDO (ES); FERNANDEZ DE LAS NIEVES IGNACI (ES); RUIZ GOMEZ GLORIA (ES); YANEZ RODRIGUEZ VICTOR (ES)
Applicant: PHARMA MAR SA (ES); LOPEZ ORTIZ FERNANDO (ES); FERNANDEZ DE LAS NIEVES IGNACI (ES); RUIZ GOMEZ GLORIA (ES); YANEZ RODRIGUEZ VICTOR (ES)
Classification:
- international: C07F9/36; A61K31/664; A61K31/675; A61P35/00; C07F9/6584; C07F9/00; A61K31/664; A61K31/675; A61P35/00;
- European:
Application number: WO2007ES00398 20070703
Priority number(s): ES20060001793 20060703
Abstract of WO2008003809
The invention relates to compounds having general formula (I) and to the corresponding pharmaceutically-acceptable salts, derivatives, pro-drugs and stereoisomers thereof, (I), which are used for the cytotoxic activity thereof and for use as antitumour agents.
Yondelis ...familiares suyos consiguen Nueva Patente
Semi-synthetic ecteinascidins .
Publication number: EP1876180
Publication date: 2008-01-09
Inventor: RINEHART KENNETH LLOYD (US); MORALES JOSE J (US)
Applicant: TRUSTEES OF THE UNIVERSITY OF (US)
Classification:
- international: C07D497/22; C07D515/22; A61K31/47; A61K31/495; A61K31/4995; A61K31/50; A61K35/56; A61P35/00; A61P35/02; C07D519/00; C07D497/00; C07D515/00; A61K31/47; A61K31/495; A61K31/4995; A61K31/50; A61K35/56; A61P35/00; C07D519/00;
- European: C07D515/22; C07D519/00
Application number: EP20070011035 19990405
Priority number(s): EP19990916379 19990405; US19980080802P 19980406
Abstract of EP1876180
The present invention is directed to several newly prepared semi-synthetic ecteinascidin (Et) species, designated herein as Et 757, Boc-Et 729, Iso-Et 743, Et 875, and Et 1560. The physical properties of these compounds, their preparation and bioactivities are also reported.
Publication number: EP1876180
Publication date: 2008-01-09
Inventor: RINEHART KENNETH LLOYD (US); MORALES JOSE J (US)
Applicant: TRUSTEES OF THE UNIVERSITY OF (US)
Classification:
- international: C07D497/22; C07D515/22; A61K31/47; A61K31/495; A61K31/4995; A61K31/50; A61K35/56; A61P35/00; A61P35/02; C07D519/00; C07D497/00; C07D515/00; A61K31/47; A61K31/495; A61K31/4995; A61K31/50; A61K35/56; A61P35/00; C07D519/00;
- European: C07D515/22; C07D519/00
Application number: EP20070011035 19990405
Priority number(s): EP19990916379 19990405; US19980080802P 19980406
Abstract of EP1876180
The present invention is directed to several newly prepared semi-synthetic ecteinascidin (Et) species, designated herein as Et 757, Boc-Et 729, Iso-Et 743, Et 875, and Et 1560. The physical properties of these compounds, their preparation and bioactivities are also reported.
Aplidin . Patente EEUU sobre sus metodos y usos AntiCancerigenos .
Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them .
Publication number: US2008009435
Publication date: 2008-01-10
Inventor: RODRIGUEZ IGNACIO (ES); POLANCO CONCEPCION (ES); CUEVAS FELIX (ES); MENDEZ PALOMA (ES); CUEVAS CARMEN (ES); GALLEGO PILAR (ES); MUNT SIMON (ES); MANZANARES IGNACIO (ES)
Applicant: PHARMA MAR S A A SPAIN CORP
Classification:
- international: A61K38/00; A61K38/12; A61P35/00; C07K1/06; C07K5/02; C07K5/083; C07K7/02; C07K11/00; C07K11/02; A61K38/00; A61K38/12; A61P35/00; C07K1/00; C07K5/00; C07K7/00; C07K11/00;
- European: C07K5/02B; C07K5/08A1B; C07K7/02
Application number: US20070788866 20070420
Priority number(s): US20070788866 20070420; GB20000016148 20000630; GB20010003750 20010215; US20030312341 20030728; WO2001GB02901 20010702
Abstract of US2008009435
The invention relates to aplidine derivatives of the general formula: which are useful for the treatment of tumors.
Publication number: US2008009435
Publication date: 2008-01-10
Inventor: RODRIGUEZ IGNACIO (ES); POLANCO CONCEPCION (ES); CUEVAS FELIX (ES); MENDEZ PALOMA (ES); CUEVAS CARMEN (ES); GALLEGO PILAR (ES); MUNT SIMON (ES); MANZANARES IGNACIO (ES)
Applicant: PHARMA MAR S A A SPAIN CORP
Classification:
- international: A61K38/00; A61K38/12; A61P35/00; C07K1/06; C07K5/02; C07K5/083; C07K7/02; C07K11/00; C07K11/02; A61K38/00; A61K38/12; A61P35/00; C07K1/00; C07K5/00; C07K7/00; C07K11/00;
- European: C07K5/02B; C07K5/08A1B; C07K7/02
Application number: US20070788866 20070420
Priority number(s): US20070788866 20070420; GB20000016148 20000630; GB20010003750 20010215; US20030312341 20030728; WO2001GB02901 20010702
Abstract of US2008009435
The invention relates to aplidine derivatives of the general formula: which are useful for the treatment of tumors.
Suscribirse a:
Entradas (Atom)